Does METILDIGOXIN Cause Therapeutic product effect decreased? 14 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Therapeutic product effect decreased have been filed in association with METILDIGOXIN. This represents 13.0% of all adverse event reports for METILDIGOXIN.
14
Reports of Therapeutic product effect decreased with METILDIGOXIN
13.0%
of all METILDIGOXIN reports
0
Deaths
14
Hospitalizations
How Dangerous Is Therapeutic product effect decreased From METILDIGOXIN?
Of the 14 reports, 14 (100.0%) required hospitalization.
Is Therapeutic product effect decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METILDIGOXIN. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does METILDIGOXIN Cause?
Dyspnoea (42)
Bradycardia (28)
Dizziness (18)
Off label use (17)
Wound haemorrhage (16)
Drug interaction (15)
General physical health deterioration (15)
Decreased appetite (14)
Medication error (14)
Pleural effusion (14)
What Other Drugs Cause Therapeutic product effect decreased?
ADALIMUMAB (11,058)
METHOTREXATE (8,952)
ETANERCEPT (8,819)
ABATACEPT (7,256)
TOCILIZUMAB (7,208)
LEFLUNOMIDE (7,025)
HYDROXYCHLOROQUINE (6,450)
INFLIXIMAB (6,401)
RITUXIMAB (6,281)
GOLIMUMAB (5,478)
Which METILDIGOXIN Alternatives Have Lower Therapeutic product effect decreased Risk?
METILDIGOXIN vs METOCLOPRAMIDE
METILDIGOXIN vs METOLAZONE
METILDIGOXIN vs METOPIMAZINE
METILDIGOXIN vs METOPROLOL
METILDIGOXIN vs METRELEPTIN